Literature DB >> 16858623

Une mort tres douce: end-of-life decisions in France; reflections from a Dutch perspective.

Margje H Haverkamp1, Johannes J M van Delden.   

Abstract

This study considers the range of thinking about end-of-life decisions (ELD) in France from a Dutch point of view, taking a small number of interviews with important French opinion-leaders as a basis. Until today, end-of-life care in France has been clouded with uncertainty pending the enactment of more specific definitions and regulations. French physicians could face a dilemma in treating a dying patient, caught between an official ban on ELD and a professional obligation to treat cases individually. The practical consequence of this climate is a lack of accountability of the French physician towards colleagues and patients. Rationalistic, paternalistic, and religious traditions have been obstructive to the adoption of regulatory reforms. In November 2004, Parliament accepted a law proposal by which the practice of the withholding and withdrawal of life-saving therapies would become more transparent, which would diminish the physician's fear of legal persecution. This proposal was then converted into law by the Senate. In the Netherlands, euthanasia - the active termination of life - is legal and regulated according to specific criteria. The Dutch approach has been shaped by an Anglo-Saxon emphasis on individual autonomy, and conforms to a broad preference in Dutch society to disclose and regulate controversial activities rather than to tolerate them sub rosa. As the Dutch regulations have been enacted, reporting rates - but not euthanasia cases - have risen. Compliance with the criteria and doctor-patient communication have been high. The French vigilance of professional autonomy provides a valuable example to the Dutch. The Dutch, in return, offer the French concrete examples for ELD policy.

Entities:  

Mesh:

Year:  2006        PMID: 16858623     DOI: 10.1007/s11019-006-9001-y

Source DB:  PubMed          Journal:  Med Health Care Philos        ISSN: 1386-7423


  8 in total

1.  Euthanasia and physician-assisted suicide: a view from an EAPC Ethics Task Force.

Authors:  Lars Johan Materstvedt; David Clark; John Ellershaw; Reidun Førde; Anne-Marie Boeck Gravgaard; H Christof Müller-Busch; Josep Porta i Sales; Charles-Henri Rapin
Journal:  Palliat Med       Date:  2003-03       Impact factor: 4.762

2.  Euthanasia and other end-of-life decisions in the Netherlands in 1990, 1995, and 2001.

Authors:  Bregje D Onwuteaka-Philipsen; Agnes van der Heide; Dirk Koper; Ingeborg Keij-Deerenberg; Judith A C Rietjens; Mette L Rurup; Astrid M Vrakking; Jean Jacques Georges; Martien T Muller; Gerrit van der Wal; Paul J van der Maas
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

3.  Euthanasia, physician-assisted suicide, and other medical practices involving the end of life in the Netherlands, 1990-1995.

Authors:  P J van der Maas; G van der Wal; I Haverkate; C L de Graaff; J G Kester; B D Onwuteaka-Philipsen; A van der Heide; J M Bosma; D L Willems
Journal:  N Engl J Med       Date:  1996-11-28       Impact factor: 91.245

4.  Withholding and withdrawal of life support in intensive-care units in France: a prospective survey. French LATAREA Group.

Authors:  E Ferrand; R Robert; P Ingrand; F Lemaire
Journal:  Lancet       Date:  2001-01-06       Impact factor: 79.321

5.  Euthanasia and other medical decisions concerning the end of life.

Authors:  P J Van Der Maas; J J Van Delden; L Pijnenborg; C W Looman
Journal:  Lancet       Date:  1991-09-14       Impact factor: 79.321

6.  Effects of euthanasia on the bereaved family and friends: a cross sectional study.

Authors:  Nikkie B Swarte; Marije L van der Lee; Johanna G van der Bom; Jan van den Bout; A Peter M Heintz
Journal:  BMJ       Date:  2003-07-26

7.  The unfeasibility of requests for euthanasia in advance directives.

Authors:  J J M van Delden
Journal:  J Med Ethics       Date:  2004-10       Impact factor: 2.903

8.  End-of-life decision-making in six European countries: descriptive study.

Authors:  Agnes van der Heide; Luc Deliens; Karin Faisst; Tore Nilstun; Michael Norup; Eugenio Paci; Gerrit van der Wal; Paul J van der Maas
Journal:  Lancet       Date:  2003-08-02       Impact factor: 79.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.